Search clinical trials for: Amlodipine%2C+Losartan

Total 973 results

Hanmi Pharmaceutical Company Limited

Completed

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

Hypertension | Aortic Stenosis | Aortic Regurgitation | Left Ventricular Hypertrophy | LVM

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension

Hypertension

Korea, Republic of
Chong-Jin Kim
Hanmi Pharmaceutical Company Limited

Completed

Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients

Hypertension

Korea, Republic of
2C Tech Corp
ORA, Inc.

Not yet recruiting

Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM)

Retinitis Pigmentosa
GlaxoSmithKline

Completed

Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions

Hypertension

South Africa
Genus Oncology, LLC

Completed

Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas

Solid Tumors

United States
Organon and Co

Completed

Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)

Hypertension
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Healthy

Czech Republic
Hanmi Pharmaceutical Company Limited

Completed

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Healthy

Czech Republic
Hanmi Pharmaceutical Company Limited

Completed

The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

Hypertension
Merck Sharp & Dohme LLC

Completed

MK-0954E Study in Participants With Hypertension (MK-0954E-357)

Hypertension
University of Pavia

Unknown

Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients

Essential Hypertension

Italy
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

Hypertension

Korea, Republic of
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Active, not recruiting

A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse

United States
GlaxoSmithKline

Completed

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers

Hypertension

Australia
Samsung Medical Center

Recruiting

Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB (REVERSE-AR)

Aortic Valve Insufficiency

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

Hypertension,Essential

Korea, Republic of
Korea University Anam Hospital
Hanmi Pharmaceutical co., ltd.

Completed

The Pharmacokinetic Interaction Between Amlodipine and Losartan

Healthy

Korea, Republic of
Taipei Veterans General Hospital, Taiwan

Completed

The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)

Ischemic Stroke
Chang Gung Memorial Hospital

Completed

EBUS-Guided TBNA Increases the Diagnostic Yield of Peripheral Pulmonary Lesions

Peripheral Pulmonary Lesions

Taiwan
Organon and Co

Completed

An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))

Proteinuria
Ullevaal University Hospital
Merck Sharp & Dohme LLC

Completed

Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)

Hypertension

Norway
The University of The West Indies
Caribbean College of Family Physicians

Withdrawn

Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

Hypertension | Diabetes Mellitus

Jamaica
Yokohama City University Medical Center

Completed

Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

Hypertension

Japan
Hanmi Pharmaceutical Company Limited

Completed

Diurnal Variation in Hypertensive Stroke Patients

Stroke | Hypertension

Korea, Republic of
Organon and Co

Completed

Cozaar XQ Re-examination Study (MK-0954-349)

Hypertension
Centro Universitario de Ciencias de la Salud, Mexico

Unknown

Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension

Hypertension

Mexico
Novartis

Completed

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension (EXALT)

Stage 2 Systolic Hypertension

United States
Ministry of Health, Labour and Welfare, Japan
Japan Cardiovascular Research Foundation

Unknown

Hypertension Control Based on Home Blood Pressure

Hypertension

Japan
Dana-Farber Cancer Institute
National Institutes of Health (NIH); Genus Oncology, LLC

Withdrawn

GO-203-2C + Bortezomib For Relapsed Or Refractory MM

Multiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in Relapse

United States
Pharmaceutical Research Unit, Jordan

Completed

Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions

Fasting

Jordan
Shanghai Jiao Tong University School of Medicine

Recruiting

Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

Hypertension

China
Organon and Co

Completed

Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)

Renal Disorder
Hotel Dieu de France Hospital

Unknown

Fixed-Free HTN Trial

Hypertension

Lebanon
Shanghai WiseGain Medical Devices Co., Ltd.

Unknown

Randomized Controlled Trial of Renal Denervation for Resistant Hypertension

Hypertension

China
Chong Kun Dang Pharmaceutical
Severance Hospital

Completed

Drug-drug Interaction Study(CKD-501, Amlodipine)

Type 2 Diabetes Mellitus

Korea, Republic of
Organon and Co

Completed

Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

Hypertension
Baker Heart and Diabetes Institute

Withdrawn

Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients

Heart Failure
Yan Li

Recruiting

Morning Versus Bedtime Dosing of Antihypertensive Medication

Hypertension | Blood Pressure | Drug Use

China
Hanmi Pharmaceutical Company Limited
Seoul National University Bundang Hospital

Completed

Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405

Hypertension(HTN)

Korea, Republic of
Columbia University

Completed

N-of-1 Trials for Blood Pressure Medications in Adults

Hypertension | High Blood Pressure

United States
University of Pavia

Unknown

Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis

Hypertension

Italy
Biomedis International Ltd.

Unknown

Recurrent Stroke Prevention Clinical Outcome Study (RESPECTS)

Stroke | Hypertension | Blood Pressure

Japan
National Institute of Diabetes and Digestive and...
Johns Hopkins University

Terminated

Losartan for the Treatment of Pediatric NAFLD (STOP-NAFLD)

NAFLD - Nonalcoholic Fatty Liver Disease

United States
Organon and Co

Completed

Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)

Heart Failure
InVasc Therapeutics, Inc.

Unknown

Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome (AMORE)

Hypertension

United States
Chinese PLA General Hospital
Tianjin TongRenTang Group Co., Ltd.

Unknown

Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis

Proteinuria | Glomerulonephritis

China

3

Subscribe